Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-08

Clinical Trial Update: Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing immediate surgery versus surgery after treatment with Sunitinib malate for patients with metastatic kidney cancer. The update notes th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunitinib malate (sunitinib malate)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Kidney Cancer | Phase 3 | Status: UNKNOWN